Literature DB >> 6907018

Lipoprotein-elastin interactions in human aorta fibrous plaque lesions.

S R Srinivasan, C Yost, B Radhakrishnamurthy, E R Dalferes, G S Berenson.   

Abstract

The nature of lipoprotein and elastin associated with hyaluronate in human atherosclerotic plaque tissue was studied by digesting the tissues with elastase. The elastase-solubilized lipoprotein-hyaluronate complexes, isolated by Bio-Gel A-50m column chromatography, contained 7.8 mg calcium/100 mg protein. The Sephadex G-200 chromatography of delipidated complexes yielded high (fraction I) and low (fraction II) molecular weight protein fractions. Dialysis of the complexes against 0.01% EDTA resulted in removal of fraction II. Fraction I reacted immunologically against antihuman LDL, and its amino acid composition resembled that of human apoB. Fraction II contained 5 peptide fragment and had high levels of nonpolar amino acids that are characteristic of elastin. However, these peptides also contained high levels of polar amino acids, thus resembling the plaque elastin. These findings suggest that certain regions of plaque elastin may have affinity for apoB containing lipoproteins and calcium.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6907018     DOI: 10.1016/0021-9150(81)90111-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  3 in total

1.  ABCC6- a new player in cellular cholesterol and lipoprotein metabolism?

Authors:  Patricia Kuzaj; Joachim Kuhn; Mareike Dabisch-Ruthe; Isabel Faust; Christian Götting; Cornelius Knabbe; Doris Hendig
Journal:  Lipids Health Dis       Date:  2014-07-27       Impact factor: 3.876

Review 2.  Lipoproteins in Cardiovascular Calcification: Potential Targets and Challenges.

Authors:  Yin Tintut; Jeffrey J Hsu; Linda L Demer
Journal:  Front Cardiovasc Med       Date:  2018-11-23

Review 3.  The structure and micromechanics of elastic tissue.

Authors:  Ellen M Green; Jessica C Mansfield; James S Bell; C Peter Winlove
Journal:  Interface Focus       Date:  2014-04-06       Impact factor: 3.906

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.